Skip to main content
AkademIndex

Products

For developers

AkademBaseOpen API for the ecosystem
← Back to work

Works cited by this work

292 works

Work: CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment

  1. Stem cells and common biomaterials in dentistry: a review study

    Seyed Ali Mosaddad, Boshra Rasoolzade, Reza Abdollahi Namanloo +2

    Review article20228 citations
    ABI

  2. Pan-cancer analysis and experiments with cell lines reveal that the slightly elevated expression of DLGAP5 is involved in clear cell renal cell carcinoma progression

    Yun Feng, Fang Li, Jing Yan +15

    Article20215 citations
    ABI

  3. Global stabilization of the full attraction-repulsion Keller-Segel system

    Hai‐Yang Jin, Zhi‐An Wang

    Article20193 citations
    ABI

  4. Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis

    Navid Shomali, Behzad Baradaran, Amin Daei Sorkhabi +12

    Article20223 citations
    ABI

  5. VEGF as a Key Mediator of Angiogenesis in Cancer

    Peter Carmeliet

    Review article20053 citations
    ABI

  6. Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells

    M.-s. Jung, Jin Kyung Rho, Y-M Kim +7

    Article20122 citations
    ABI

  7. Tempol effect on epithelial-mesenchymal transition induced by hyperglycemia

    Mohammad Jafari, Farahnaz Dadras, Hamid Reza Ghadimipour +2

    Article20162 citations
    ABI

  8. Epithelial and endothelial mesenchymal transition and their role in diabetic kidney disease

    Farahnaz Dadras, Vida Sheikh, Farhad Khoshjou

    Article20172 citations
    ABI

  9. RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer

    Xinbing Sui, Ruonan Zhang, Shuiping Liu +8

    Article20182 citations
    ABI

  10. Factors associated with delayed diagnosis of breast cancer; a study in North-West of Iran

    Nasrin Fouladi, Maedeh Barahman, Firouz Amani +2

    Article20192 citations
    ABI

  11. The emerging molecular mechanism of m6A modulators in tumorigenesis and cancer progression

    Shuiping Liu, Qiujie Li, Ke Chen +7

    Review article20202 citations
    ABI

  12. <p>Nanoparticle Drug Delivery System for Glioma and Its Efficacy Improvement Strategies: A Comprehensive Review</p>

    Jie Li, Jiaqian Zhao, Tiantian Tan +7

    Review article20202 citations
    ABI

  13. Efficient isolation and identification of primary endothelial cells from bovine aorta by collagenase P

    Faezeh Seif, Alireza Kheirollah, Hossein Babaahmadi‐Rezaei

    Article20202 citations
    ABI

  14. Relation between Immune cell response and stemness genes expression in breast cancer; A new approach in NANOG gene and Let7-a expression in breast cancer cell lines

    Zeynab Aliyari-Serej, Ayyub Ebrahımı, Tohid Kazemi +4

    Article20202 citations
    ABI

  15. Dual inhibitors of histone deacetylases and other cancer-related targets: A pharmacological perspective

    Yuan Gao, Hang Zhang, Frédéric Lirussi +3

    Review article20202 citations
    ABI

  16. Small molecule DNA-PK inhibitors as potential cancer therapy: a patent review (2010–present)

    Suwen Hu, Zi Hui, Frédéric Lirussi +3

    Review article20202 citations
    ABI

  17. MgFe‐LDH Nanoparticles: A Promising Leukemia Inhibitory Factor Replacement for Self‐Renewal and Pluripotency Maintenance in Cultured Mouse Embryonic Stem Cells

    Xiaolie He, Yanjing Zhu, Li Yang +6

    Article20212 citations
    ABI

  18. Prognostic implication of PD-L1 expression and associated tumor infiltrating lymphocytes in metastatic breast cancer

    Mohamed M Darwish, Atef Youssef Riad, Dina Salem +3

    Article20212 citations
    ABI

  19. Lung cancer risk and the inhibitors of angiotensin converting enzyme; an updated review on recent evidence

    Maryam Khosravian, Mahnaz Momenzadeh, Farzad Koosha +2

    Article20212 citations
    ABI

  20. The regulatory role of autophagy-related miRNAs in lung cancer drug resistance

    Mahshid Shahverdi, Khalil Hajiasgharzadeh, Amin Daei Sorkhabi +9

    Review article20222 citations
    ABI

  21. RETRACTED: Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies

    Navid Shomali, Marwah Suliman Maashi, Behzad Baradaran +7

    Review article20222 citations
    ABI

  22. The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme

    Amin Daei Sorkhabi, Aila Sarkesh, Hossein Saeedi +5

    Review article20222 citations
    ABI

  23. Cancer combination therapies by silencing of CTLA‐4, PD‐L1, and TIM3 in osteosarcoma

    Amin Daei Sorkhabi, Aila Sarkesh, Ali Fotouhi +2

    Article20222 citations
    ABI

  24. Evaluation of the urine mRNA-PCA3 expression level in prostate patients; comparison between benign prostatic hyperplasia and cancer

    Amid Yazdani, Farshad Namdari, Sattar Gorgani‐Firuzjaee +1

    Article20222 citations
    ABI

  25. Survival rates and prognostic factors of thyroid cancer: A retrospective cohort study

    Ali Amri, Ali Reza Soltanian, Shiva Borzouei

    Article20222 citations
    ABI